Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$166 Hold
3
﹤0.01% 687
2022
Q1
$212 Sell
3
-605
-100% -$38.7K ﹤0.01% 961
2021
Q4
$35.7K Buy
608
+597
+5,427% +$37K 0.01% 537
2021
Q3
$638 Hold
11
﹤0.01% 912
2021
Q2
$615 Hold
11
﹤0.01% 922
2021
Q1
$557 Hold
11
﹤0.01% 787
2020
Q4
$422 Hold
11
﹤0.01% 752
2020
Q3
$286 Hold
11
﹤0.01% 709
2020
Q2
$365 Hold
11
﹤0.01% 632
2020
Q1
$240 Hold
11
﹤0.01% 650
2019
Q4
$835 Sell
11
-8,962
-100% -$641K ﹤0.01% 558
2019
Q3
$661K Buy
+8,973
New +$635K 0.12% 136
2018
Q4
Sell
-1
Closed -$68 722
2018
Q3
$68 Hold
1
﹤0.01% 636
2018
Q2
$70 Hold
1
﹤0.01% 628
2018
Q1
$56 Hold
1
﹤0.01% 568
2017
Q4
$53 Hold
1
﹤0.01% 564
2017
Q3
$55 Buy
+1
New +$54 ﹤0.01% 533

Other funds holding OKE

Exane Derivatives's OKE Position: Q2 2022 in Review

Exane Derivatives held its Oneok (OKE) position steady in Q2 2022 at 3 shares worth $166. The position accounts for ﹤0.01% of the portfolio, ranked #687.

Exane Derivatives first reported a position in OKE in Q3 2017 and has held it in 17 quarters since. The position peaked at $661K in Q3 2019. 978 funds tracked by Wall St. Rank hold OKE as of Q2 2022.

  • Exane Derivatives held 3 shares of Oneok worth $166 as of Q2 2022.
  • Exane Derivatives left its Oneok share count unchanged in Q2 2022.
  • Oneok made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #687 holding.
  • Exane Derivatives first reported a position in Oneok in Q3 2017 and has held it in 17 quarters since.
  • Exane Derivatives's Oneok position peaked at $661K in Q3 2019.
  • 978 funds tracked by Wall St. Rank held Oneok as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.